B+ Awards $2,250,000!
The Andrew McDonough B+ Foundation Awards $2.25MM in Research Grants!
I am very proud to share with you the listing of our latests grants. If you would like a little more detail, please visit our research grants page on our website.
We normally have about 45 applications in a grant cycle. Due to several factors, we received 94 applications this past year! For perspective, each application is over 50 pages. Much appreciation to our 12 world-class Scientific Advisory Board Members (check out their brief bios here) for selecting the 15 most promising.
This is the kind of work that is changing the landscape of childhood cancer and you make it possible.
Thank you!!!
Dr. Sahaja Acharya – Johns Hopkins - In a FLASH: reducing toxicity and enhancing cure for pediatric brain tumors
Dr. Nicole Anderson – University of Mississippi - Identify Genetic Drivers Metastasis Using an Established Zebrafish Model of High-Risk Neuroblastoma
Dr. Darko Barisic – Weill Cornell Medicine - Precision Epigenetic Therapies for Pediatric Burkitt Lymphoma
Dr. Mark Chiang – University of Michigan - Deciphering mutually exclusive T-ALL and neurodevelopmental mutations in the ARD domain of the ZMIZ1 coactivator
Dr. Roshni Dasgupta – Cincinnati Children’s Hospital - Development and Validation of Patient-Reported Outcome Measures for Pediatric Cancer Surgery
Dr. Eran Elinav – Weizmann Institute - Linking the Gut Microbiome to Chemotherapy Toxicity in Pediatric ALL
Dr. Furqan Fazal – Baylor College of Medicine -
Mapping Mitochondrial-localized mRNA Translational Rewiring in Radiation-resistant Pediatric DIPG
Dr. Yuan Gao – Case Western Reserve - Dissecting Ewing Sarcoma On-Chip for Better Therapeutics
Dr. Gunda Georg- University of Minnesota - Tumor-specific PROTAC development as a new therapeutic approach for osteosarcoma
Dr. Brandon Hadland – Fred Hutchinson Cancer Center - Dissecting CBFA2T3-GLIS2 Fusion-Driven Leukemogenesis and Therapeutic Resistance
Dr. Daniel Herranz – Rutgers University - GLUL as a novel therapeutic target in pediatric T-ALL
Dr. Matthew Hocking – Children’s Hospital of Philadelphia -
Development of a Measure of Social Connectedness for Survivors of Pediatric Brain Tumors
Dr. Jihye Paik – Weill Cornell Medicine - Targeting ALT-Associated Vulnerabilities in Pediatric High-Grade Glioma
Dr. John Prensner – University of Michigan - Inhibition of the RNA translation factor, eIF4E, as a novel treatment strategy in Ewing Sarcoma
Dr. Gengwen Tian – Baylor College of Medicine - Enhancing GD2-CAR NKT anti-tumor efficacy against neuroblastoma by targeting BLIMP1
Ali & Andrew’s Dad